Is it time for a large trial to evaluate aspirin for obstetric venous thromboembolism prophylaxis?
Lancet Haematol
.
2025 Jan 15:S2352-3026(24)00374-0.
doi: 10.1016/S2352-3026(24)00374-0.
Online ahead of print.
Author
Alexander M Friedman
1
Affiliation
1
Division of Maternal-Fetal Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: amf2104@cumc.columbia.edu.
PMID:
39827893
DOI:
10.1016/S2352-3026(24)00374-0
No abstract available